Why Minerva Neurosciences Is Trading Higher
January 21, 2015 at 21:21 PM EST
After the close, Minerva Neurosciences Inc (NASDAQ: NERV) reported positive Phase 1 data with MIN-202 for treatment of sleep ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.